Skip to main content

ProShare Advisors LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in CLDX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$380,918
+$79,801 QoQ
Shares Held
10,237
+7.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#157
of 252 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. CLDX ranks #67 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLDX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $380,918 10,237
2026-03-31 $301,117 9,493
2025-12-31 $325,186 11,973
2025-09-30 $289,744 11,200
2025-06-30 $273,300 13,430
2025-03-31 $253,845 13,986
2024-12-31 $459,711 18,192
2024-09-30 $414,881 12,206
2024-06-30 $308,071 8,324
2024-03-31 $468,637 11,166
2023-12-31 $304,985 7,690
2023-06-30 $205,038 6,043
2022-12-31 $262,784 5,896
2022-03-31 $293,869 8,628
2021-12-31 $387,984 10,041
2021-09-30 $318,271 5,895
2021-06-30 $340,118 10,171